238 related articles for article (PubMed ID: 26646562)
21. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
[TBL] [Abstract][Full Text] [Related]
22. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
24. Effects of Caspase 9 Gene Polymorphism in Patients with Prostate Cancer.
Yilmaz SG; Yencilek F; Yildirim A; Yencilek E; Isbir T
In Vivo; 2017; 31(2):205-208. PubMed ID: 28358701
[TBL] [Abstract][Full Text] [Related]
25. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
26. PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.
Yang XD; Zhao SF; Zhang Q; Li W; Wang YX; Hong XW; Hu QG
Tumour Biol; 2016 Jan; 37(1):577-82. PubMed ID: 26232326
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
[TBL] [Abstract][Full Text] [Related]
28. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
[TBL] [Abstract][Full Text] [Related]
30. Association Between WRN Cys1367Arg (T>C) and Cancer Risk: A Meta-analysis.
Wang B; Li G; Sun F; Dong N; Sun Z; Jiang D
Technol Cancer Res Treat; 2016 Feb; 15(1):20-7. PubMed ID: 25468760
[TBL] [Abstract][Full Text] [Related]
31. A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk.
Tao L; Chen J; Zhou H; Qin C; Li P; Cao Q; Li J; Ju X; Zhu C; Wang M; Zhang Z; Shao P; Yin C
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):95-100. PubMed ID: 23045290
[TBL] [Abstract][Full Text] [Related]
32. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
Chen CH; Gong M; Yi QT; Guo JH
Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
[TBL] [Abstract][Full Text] [Related]
33. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
34. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
35. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E Genotypes in Patients with Prostate Cancer.
Yencilek F; Yilmaz SG; Yildirim A; Gormus U; Altinkilic EM; Dalan AB; Bastug Y; Turkmen S; Turkan S; Isbir T
Anticancer Res; 2016 Feb; 36(2):707-11. PubMed ID: 26851028
[TBL] [Abstract][Full Text] [Related]
37. The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.
Men T; Yu C; Wang D; Liu F; Li J; Qi X; Yang C; Jiang W; Wei X; Li X; Wang B; Mi J; Tian G
Oncotarget; 2017 Jul; 8(28):45994-46005. PubMed ID: 28526808
[TBL] [Abstract][Full Text] [Related]
38. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
39. Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese.
Chen J; Wu Y; Shao P; Cao Q; Qin C; Li P; Ding Q; Zhu J; Wang M; Zhang Z; Li J; Yin C
DNA Cell Biol; 2012 May; 31(5):790-6. PubMed ID: 22084938
[TBL] [Abstract][Full Text] [Related]
40. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
Chen C; Xin Z
Medicine (Baltimore); 2017 Mar; 96(10):e6280. PubMed ID: 28272245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
